{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 0,
        "end": 11
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 26,
        "end": 30
      }
    },
    {
      "id": "T4",
      "obj": "Disease",
      "span": {
        "begin": 172,
        "end": 192
      }
    },
    {
      "id": "T6",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 208,
        "end": 212
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 33,
        "end": 81
      }
    },
    {
      "id": "T8",
      "obj": "Chemical",
      "span": {
        "begin": 26,
        "end": 100
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 112,
        "end": 131
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "23909652_2",
  "text": "Vemurafenib , a selective BRAF ( v-raf murine sarcoma viral oncogene homologue B1 ) kinase inhibitor , is a new targeted biotherapy that improves survival in patients with metastatic melanomas harbouring the BRAF V600E mutation ."
}
